欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5725/001
药品名称Nintedanib Sandoz 100 mg, zachte capsules
活性成分
    • nintedanib esilate 100.0 mg
剂型Capsule, soft
上市许可持有人Sandoz B.V. Hospitaaldreef 29 1315 RC Almere The Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Austria (AT)
    • Estonia (EE)
    • France (FR)
    • Hungary (HU)
      Nintedanib Sandoz 100 mg lágy kapszula
    • Spain (ES)
    • Czechia (CZ)
      Nintedanib Sandoz
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Denmark (DK)
      Nintedanib Sandoz
    • Latvia (LV)
    • Iceland (IS)
    • Lithuania (LT)
      Nintedanib Sandoz 100 mg minkštosios kapsulės
许可日期2024/10/02
最近更新日期2024/10/31
药物ATC编码
    • L01EX09 nintedanib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase